Specialist recommendation for chemoprevention medications in patients at familial risk of breast cancer: a cross-sectional survey in England

In England, the National Institute for Health and Care Excellence guideline for familial breast cancer recommends chemoprevention for women at high and moderate familial risk of breast cancer. However, prescribing of chemoprevention has not improved since the introduction of the guideline in 2013. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Siang Ing, Curtis, Helen, Qureshi, Sadaf, Dutton, Brittany, Qureshi, Nadeem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846641/
https://www.ncbi.nlm.nih.gov/pubmed/33118147
http://dx.doi.org/10.1007/s12687-020-00490-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846641/
https://www.ncbi.nlm.nih.gov/pubmed/33118147
http://dx.doi.org/10.1007/s12687-020-00490-4

Ejemplares similares